In the present study, luciferase reporter assays were conducted, and it was found that FOXD2-AS1 could bind miR-506-5p, which is associated with tumors and is abnormally expressed in various cancers including glioma [29,30,31]. Here, FOXD2 is linked to central nervous system cancer.